Physician profile
Michael Cooper
NPI 1649239807
$3,576.08
in general payments reported to CMS, 2019-2025
13 companies · $22.68 in 2025
The $22.68 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,106 · 2020: $48.30 · 2021: $366 · 2022: $601 · 2023: $1,285 · 2024: $147 · 2025: $22.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $813 · Food and Beverage: $642.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $813.30 |
| Food and Beverage | $641.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $1,322.20 | 2019-2025 | Zenith Alpha, Zenith, Zilver 635 |
| W. L. Gore & Associates, INC. | $1,159.24 | 2019-2024 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Shockwave Medical, INC | $498.45 | 2021-2022 | |
| Abbvie INC. | $174.71 | 2021-2022 | |
| Medtronic, INC. | $170.85 | 2021 | |
| Medtronic Vascular, INC. | $77.96 | 2019 | |
| Tactile Systems Technology INC | $73.22 | 2019-2022 | |
| Boston Scientific Corporation | $21.13 | 2021 | |
| Abbott Laboratories | $19.41 | 2019 | |
| Bard Peripheral Vascular, INC. | $19.08 | 2020 | |
| Getinge USA Sales, LLC | $15.64 | 2021 | |
| Glaxosmithkline, LLC. | $13.03 | 2023 | Shingrix |
| Smith+Nephew, INC. | $11.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.